Anti-KCTD16 antibodies are used in the immunodetection of the protein potassium channel tetramerization domain containing 16. In humans, the canonical protein has a reported length of 428 amino acid residues and a mass of 49.1 kDa. Its subcellular localization is in the cell membrane. It is notably expressed in the hippocampus, cerebral cortex, cerebellum, and caudate. KCTD16 is reported to be an auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Synonyms for this target antigen include potassium channel tetramerisation domain containing 16, potassium channel tetramerization domain-containing protein 16, and BTB/POZ domain-containing protein KCTD16. KCTD16 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Western Blot is the most common application for the KCTD16 antibodies listed below. Immunofluorescence and Immunohistochemistry are also common applications.